Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3Active not recruiting 3Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2CNS 2Sarcoma 1Other hematologic neoplasm 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Fatigue 1Breast Neoplasms 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Transcranial Direct Current Stimulation × Breast × Clear all
NCT03487601 2021-01-15

Transcranial Direct Current Stimulation (tDCS) to Improve Fatigue and Cognitive Function

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed
3 enrolled
Breast

Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡